Alcyone Lifesciences

Alcyone Lifesciences, Inc. is a biotechnology company dedicated to developing innovative treatment options for oncology and chronic neurological conditions. Founded in 2010 and headquartered in Lowell, Massachusetts, the company specializes in advanced delivery systems, notably the Alcyone MEMS Cannula system, which allows neurosurgeons to accurately target regions within the brain and deliver therapeutic agents with real-time MRI guidance. This technology addresses significant challenges in treating various neurologic disorders, including brain tumors, hydrocephalus, epilepsy, and neurodegenerative diseases, particularly by overcoming the limitations posed by the blood-brain barrier. Alcyone Lifesciences aims to enhance molecular therapy precision and control, thereby transforming treatment approaches for rare and orphan neurological disorders.